{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:27:22Z","timestamp":1790508442741,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11010-019-03531-w","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T08:03:47Z","timestamp":1555661027000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Repetitive transcranial magnetic stimulation protects mice against 6-OHDA-induced Parkinson\u2019s disease symptoms by regulating brain amyloid \u03b21\u201342 level"],"prefix":"10.1007","volume":"458","author":[{"given":"Fang","family":"Ba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5802-3091","authenticated-orcid":false,"given":"Xueyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"issue":"5","key":"3531_CR1","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1212\/01.wnl.0000341769.50075.bb","volume":"72","author":"JA Driver","year":"2009","unstructured":"Driver JA, Logroscino G, Gaziano JM, Kurth T (2009) Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology 72(5):432\u2013438. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000341769.50075.bb","journal-title":"Neurology"},{"issue":"2","key":"3531_CR2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.22588","volume":"71","author":"AS Buchman","year":"2012","unstructured":"Buchman AS, Shulman JM, Nag S, Leurgans SE, Arnold SE, Morris MC, Schneider JA, Bennett DA (2012) Nigral pathology and parkinsonian signs in elders without Parkinson\u2019s disease. Ann Neurol 71(2):258\u2013266","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"3531_CR3","first-page":"1783","volume":"363","author":"AJ Lees","year":"2004","unstructured":"Lees AJ, Hardy J, Revesz T (2004) Parkinson\u2019s disease. Lancet 363(Suppl):1783\u20131793","journal-title":"Lancet"},{"issue":"4","key":"3531_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","volume":"84","author":"C Marras","year":"2013","unstructured":"Marras C, Lang A (2013) Parkinson\u2019s disease subtypes: lost in translation? J Neurol Neurosur Ps 84(4):409\u2013415. \n                    https:\/\/doi.org\/10.1136\/jnnp-2012-303455","journal-title":"J Neurol Neurosur Ps"},{"issue":"3","key":"3531_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2010.04.020","volume":"39","author":"KD Dijk van","year":"2010","unstructured":"van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, Berendse HW, van de Berg WD (2010) Diagnostic cerebrospinal fluid biomarkers for Parkinson\u2019s disease: a pathogenetically based approach. Neurobiol Dis 39(3):229\u2013241. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2010.04.020","journal-title":"Neurobiol Dis"},{"issue":"11","key":"3531_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D (2010) Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol 9(11):1044\u20131045","journal-title":"Lancet Neurol"},{"issue":"5","key":"3531_CR7","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2217\/bmm.10.84","volume":"4","author":"J Nyhl\u00e9n","year":"2010","unstructured":"Nyhl\u00e9n J, Constantinescu R, Zetterberg H (2010) Problems associated with fluid biomarkers for Parkinson\u2019s disease. Biomarkers Med 4(5):671\u2013681","journal-title":"Biomarkers Med"},{"issue":"3","key":"3531_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","volume":"9","author":"L Parnetti","year":"2013","unstructured":"Parnetti L, Castrioto A, Chiasserini D, Persichetti E, Tambasco N, El-Agnaf O, Calabresi P (2013) Cerebrospinal fluid biomarkers in Parkinson disease. Nat Rev Neurol 9(3):131\u2013140","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"3531_CR9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/mds.26172","volume":"30","author":"LM Bekris","year":"2015","unstructured":"Bekris LM, Tsuang DW, Peskind ER, Yu CE, Montine TJ, Zhang J, Zabetian CP, Leverenz JB (2015) Cerebrospinal fluid A\u03b242 levels and APP processing pathway genes in Parkinson\u2019s disease. Movement Disord 30(7):936\u2013944","journal-title":"Movement Disord"},{"issue":"4","key":"3531_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/bmm.12.47","volume":"6","author":"H Zetterberg","year":"2012","unstructured":"Zetterberg H, Lunn MP, Herukka SK (2012) Clinical use of cerebrospinal fluid biomarkers in Alzheimer\u2019s disease. Biomarkers Med 6(4):371\u2013376","journal-title":"Biomarkers Med"},{"issue":"2","key":"3531_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/156720508783954668","volume":"5","author":"R Postina","year":"2008","unstructured":"Postina R (2008) A closer look at alpha-secretase. Curr Alzheimer Res 5(2):179\u2013186","journal-title":"Curr Alzheimer Res"},{"key":"3531_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/156720508783954686","volume":"5","author":"M Deuss","year":"2008","unstructured":"Deuss M, Reiss K, Hartmann D (2008) Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr Alzheimer Res 5:2","journal-title":"Curr Alzheimer Res"},{"issue":"10","key":"3531_CR13","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1172\/JCI20864","volume":"113","author":"R Postina","year":"2004","unstructured":"Postina R, Schroeder A, Dewachter I, Bohl J, Schmitt U, Kojro E, Prinzen C, Endres K, Hiemke C, Blessing M (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J Clin Invest 113(10):1456","journal-title":"J Clin Invest"},{"issue":"2","key":"3531_CR14","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF03402076","volume":"8","author":"F Colciaghi","year":"2002","unstructured":"Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di LM (2002) [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mo Med 8(2):67","journal-title":"Mo Med"},{"issue":"1","key":"3531_CR15","doi-asserted-by":"publisher","first-page":"e4183","DOI":"10.1371\/journal.pone.0004183","volume":"4","author":"W Qin","year":"2009","unstructured":"Qin W, Ho L, Wang J, Peskind E, Pasinetti GM (2009) S100A7, a novel Alzheimer\u2019s disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10. PLoS ONE 4(1):e4183","journal-title":"PLoS ONE"},{"issue":"8","key":"3531_CR16","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","volume":"65","author":"H Zetterberg","year":"2008","unstructured":"Zetterberg H, Andreasson U, Hansson O, Wu G, Sankaranarayanan S, Andersson ME, Buchhave P, Londos E, Umek RM, Minthon L (2008) Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol-Chicago 65(8):1102\u20131107","journal-title":"Arch Neurol-Chicago"},{"issue":"12","key":"3531_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.clinbiochem.2008.04.022","volume":"41","author":"G Wu","year":"2008","unstructured":"Wu G, Sankaranarayanan S, Tugusheva K, Kahana J, Seabrook G, Shi XP, King E, Devanarayan V, Cook JJ, Simon AJ (2008) Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer\u2019s subjects. Clin Biochem 41(12):986\u2013996","journal-title":"Clin Biochem"},{"issue":"5","key":"3531_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/awn034","volume":"131","author":"M Ewers","year":"2008","unstructured":"Ewers M, Zhong Z, B\u00fcrger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H (2008) Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer\u2019s disease. Brain 131(5):1252\u20131258","journal-title":"Brain"},{"issue":"7","key":"3531_CR19","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1096\/fj.04-3426com","volume":"19","author":"X Sun","year":"2005","unstructured":"Sun X, Wang Y, Qing H, Christensen MA, Liu Y, Zhou W, Tong Y, Xiao C, Huang Y, Zhang S (2005) Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J 19(7):739\u2013749","journal-title":"FASEB J"},{"issue":"3","key":"3531_CR20","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1042\/BST0350574","volume":"35","author":"JH Stockley","year":"2007","unstructured":"Stockley JH, O\u2019Neill C (2007) The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer\u2019s disease brain. Biochem Soc Trans 35(3):574\u2013576","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"3531_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1534-5807(02)00189-2","volume":"3","author":"J Zhang","year":"2002","unstructured":"Zhang J (2002) aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3(1):85\u201397","journal-title":"Dev Cell"},{"issue":"2","key":"3531_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0969-9961(03)00123-2","volume":"14","author":"S Baulac","year":"2003","unstructured":"Baulac S, Lavoie MJ, Kimberly WT, Strahle J, Wolfe MS, Selkoe DJ, Xia W (2003) Functional gamma-secretase complex assembly in Golgi\/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. Neurobiol Dis 14(2):194\u2013204","journal-title":"Neurobiol Dis"},{"issue":"11","key":"3531_CR23","doi-asserted-by":"publisher","first-page":"6382","DOI":"10.1073\/pnas.1037392100","volume":"100","author":"WT Kimberly","year":"2003","unstructured":"Kimberly WT, Lavoie MJ, Ostaszewski BL, Ye W, Wolfe MS, Selkoe DJ (2003) \u03b3-secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and Pen-2. Proc Natl Acad Sci USA 100(11):6382\u20136387","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"3531_CR24","doi-asserted-by":"publisher","first-page":"7521","DOI":"10.1523\/JNEUROSCI.6751-10.2011","volume":"31","author":"R Gersner","year":"2011","unstructured":"Gersner R, Kravetz E, Feil J, Pell G, Zangen A (2011) Long-term effects of repetitive transcranial magnetic stimulation on markers for neuroplasticity: differential outcomes in anesthetized and awake animals. J Neurosci 31(20):7521\u20137526","journal-title":"J Neurosci"},{"issue":"30","key":"3531_CR25","doi-asserted-by":"publisher","first-page":"11044","DOI":"10.1523\/JNEUROSCI.2125-11.2011","volume":"31","author":"HY Wang","year":"2011","unstructured":"Wang HY, Crupi D, Liu J, Stucky A, Cruciata G, Di RA, Friedman E, Quartarone A, Ghilardi MF (2011) Repetitive transcranial magnetic stimulation enhances BDNF-TrkB signaling in both brain and lymphocyte. J Neurosci 31(30):11044\u201311054","journal-title":"J Neurosci"},{"issue":"7","key":"3531_CR26","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.clinph.2006.04.009","volume":"117","author":"PC Miranda","year":"2006","unstructured":"Miranda PC, Lomarev M, Hallett M (2006) Modeling the current distribution during transcranial direct current stimulation. Clin Neurophysio 117(7):1623\u20131629","journal-title":"Clin Neurophysio"},{"issue":"12","key":"3531_CR27","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1136\/jnnp.2005.069849","volume":"76","author":"F Fregni","year":"2005","unstructured":"Fregni F, Simon D, Wu A, Pascual-Leone A (2005) Non-invasive brain stimulation for Parkinson\u2019s disease: a systematic review and meta-analysis of the literature. J Neurol Neurosur Psychiatry 76(12):1614","journal-title":"J Neurol Neurosur Psychiatry"},{"issue":"8","key":"3531_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.exger.2013.05.001","volume":"48","author":"T Tan","year":"2013","unstructured":"Tan T, Xie J, Liu T, Chen X, Zheng X, Tong Z, Tian X (2013) Low-frequency (1\u00a0Hz) repetitive transcranial magnetic stimulation (rTMS) reverses A\u03b2(1\u201342)-mediated memory deficits in rats. Exp Gerontol 48(8):786\u2013794","journal-title":"Exp Gerontol"},{"issue":"3","key":"3531_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, Zhou B, Wernig M, S\u00fcdhof TC (2017) ApoE2, ApoE3, and ApoE4 differentially stimulate app transcription and A\u03b2 secretion. Cell 168(3):427","journal-title":"Cell"},{"issue":"7","key":"3531_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrn2169","volume":"8","author":"MC Ridding","year":"2007","unstructured":"Ridding MC, Rothwell JC (2007) Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci 8(7):559\u2013567","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"3531_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-015-0045-x","volume":"4","author":"Z Ni","year":"2015","unstructured":"Ni Z, Chen R (2015) Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases. Transl Neurodegener 4(1):22","journal-title":"Transl Neurodegener"},{"issue":"1","key":"3531_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1755-7682-1-2","volume":"1","author":"AC Oscar","year":"2008","unstructured":"Oscar AC (2008) Basic mechanisms of rTMS: implications in Parkinson\u2019s disease. Int Arch Med 1(1):2","journal-title":"Int Arch Med"},{"issue":"8","key":"3531_CR33","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1111\/j.1476-5381.2010.00669.x","volume":"159","author":"M Colaianna","year":"2010","unstructured":"Colaianna M, Tucci P, Zotti M, Morgese MG, Schiavone S, Govoni S, Cuomo V, Trabace L (2010) Soluble \u03b2amyloid1\u201342: a critical player in producing behavioural and biochemical changes evoking depressive-related state? Br J Pharmacol 159(8):1704","journal-title":"Br J Pharmacol"},{"issue":"2","key":"3531_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0169-328X(00)00023-1","volume":"76","author":"RM Holsinger","year":"2000","unstructured":"Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M (2000) Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer\u2019s disease. Mol Brain Res 76(2):347\u2013354","journal-title":"Mol Brain Res"},{"issue":"8","key":"3531_CR35","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/mds.23670","volume":"26","author":"L Parnetti","year":"2011","unstructured":"Parnetti L, Chiasserini D, Bellomo G, Giannandrea D, De CC, Qureshi MM, Ardah MT, Varghese S, Bonanni L, Borroni B (2011) Cerebrospinal fluid Tau\/\u03b1-synuclein ratio in Parkinson\u2019s disease and degenerative dementias. Mov Disord 26(8):1428\u20131435","journal-title":"Mov Disord"},{"issue":"3","key":"3531_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/mds.22364","volume":"24","author":"B Elahi","year":"2010","unstructured":"Elahi B, Chen R (2010) Effect of transcranial magnetic stimulation on Parkinson motor function\u2013systematic review of controlled clinical trials. Mov Disord 24(3):357\u2013363","journal-title":"Mov Disord"},{"issue":"6","key":"3531_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/mds.26206","volume":"30","author":"A Zanjani","year":"2015","unstructured":"Zanjani A, Zakzanis KK, Daskalakis ZJ, Chen R (2015) Repetitive transcranial magnetic stimulation of the primary motor cortex in the treatment of motor signs in Parkinson\u2019s disease: a quantitative review of the literature. Mov Disord 30(6):750\u2013758","journal-title":"Mov Disord"},{"issue":"5","key":"3531_CR38","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1212\/WNL.48.5.1398","volume":"48","author":"NS Nielsen","year":"1997","unstructured":"Nielsen NS, Jacobsen C (1997) Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48(5):1398\u20131403","journal-title":"Neurology"},{"issue":"9","key":"3531_CR39","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1212\/01.wnl.0000256036.20927.a5","volume":"68","author":"A Wagleshukla","year":"2007","unstructured":"Wagleshukla A, Angel MJ, Zadikoff C, Enjati M, Gunraj C, Lang AE, Chen R (2007) Low-frequency repetitive transcranial magnetic stimulation for treatment of levodopa-induced dyskinesias. Neurology 68(9):704\u2013705","journal-title":"Neurology"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-019-03531-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-019-03531-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:07:16Z","timestamp":1587164836000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-019-03531-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["3531"],"URL":"https:\/\/doi.org\/10.1007\/s11010-019-03531-w","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]},"assertion":[{"value":"4 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors disclose no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}